HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study

INTRODUCTION: Evidence supports high-risk human papilloma virus (HPV) testing as the primary cervical cancer screening tool. However, benefits and harms should be carefully considered before replacing liquid-based cytology. In women age 50 and older, we evaluated how a commercially available DNA amp...

Descripción completa

Detalles Bibliográficos
Autores principales: Andersen, Berit, Njor, Sisse Helle, Jensen, Anne Marie Schak, Johansen, Tonje, Jeppesen, Ulla, Svanholm, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656146/
https://www.ncbi.nlm.nih.gov/pubmed/33037107
http://dx.doi.org/10.1136/ijgc-2020-001457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656146/
https://www.ncbi.nlm.nih.gov/pubmed/33037107
http://dx.doi.org/10.1136/ijgc-2020-001457

Ejemplares similares